Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, et al.
EBioMedicine (2023) Vol. 90, pp. 104545-104545
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

SARS-CoV-2 evolution in the Omicron era
Cornelius Roemer, Daniel J. Sheward, Ryan Hisner, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1952-1959
Closed Access | Times Cited: 73
Implications of diversity in sperm size and function for sperm competition and fertility
Montserrat Gomendio, Eduardo R. S. Roldán
The International Journal of Developmental Biology (2008) Vol. 52, Iss. 5-6, pp. 439-447
Open Access | Times Cited: 182
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1
David J. Sullivan, Massimo Franchini, Jonathon W. Senefeld, et al.
Journal of General Virology (2023) Vol. 104, Iss. 5
Open Access | Times Cited: 30
Sensitivity of BA.2.86 to prevailing neutralising antibody responses
Daniel J. Sheward, Yiqiu Yang, Michelle Westerberg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 21
spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland
Arshnee Moodley, Marc Stegger, Arzu Funda BAĞCIGİL, et al.
Journal of Antimicrobial Chemotherapy (2006) Vol. 58, Iss. 6, pp. 1118-1123
Open Access | Times Cited: 148
Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 5
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
Tetsuya Inoue, Yuichiro Yamamoto, Kaoru Sato, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109363-109363
Open Access | Times Cited: 5
Remdesivir and Obeldesivir Retain Potent Antiviral Activity Against SARS-CoV-2 Omicron Variants
Lauren Rodriguez, J. Lizbeth Reyes Zamora, Dong Han, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 168-168
Open Access
Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates
Ranajit Pal, Maria Grazia Ferrari, Yoshikazu Honda‐Okubo, et al.
Vaccine (2024) Vol. 42, Iss. 5, pp. 1122-1135
Closed Access | Times Cited: 4
Australia’s COVID-19 vaccine journey: progress and future perspectives
James A. Triccas, Megan Steain
Microbiology Australia (2024)
Open Access | Times Cited: 4
Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5
Carolina Torres, Mercedes Nabaes Jodar, Dolores Acuña, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 312-312
Open Access | Times Cited: 11
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1
David J. Sullivan, Massimo Franchini, Jonathon W. Senefeld, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17
Retrospective Evaluation of Partial Parenteral Nutrition in Dogs and Cats
Daniel L. Chan, Lisa M. Freeman, Mary Anna Labato, et al.
Journal of Veterinary Internal Medicine (2002) Vol. 16, Iss. 4, pp. 440-440
Open Access | Times Cited: 63
Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants
Yoshikazu Honda‐Okubo, Richard A. Bowen, Mckinzee Barker, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7116-7128
Closed Access | Times Cited: 8
Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain
Itsuki Anzai, Junso Fujita, Chikako Ono, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants
Lok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
EBioMedicine (2024) Vol. 110, pp. 105461-105461
Open Access | Times Cited: 2
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model
Takuya Tada, Julia Minnee, Nathaniel R. Landau
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 23
Open Access | Times Cited: 6
Increase in SARS-CoV-2 Seroprevalence in UK Domestic Felids Despite Weak Immunogenicity of Post-Omicron Variants
Grace Tyson, Sarah Jones, Chloé Montreuil-Spencer, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1661-1661
Open Access | Times Cited: 6
Diagnostic Tests: Testing for COVID-19: a 2023 update
Ella M. Meumann, Jennifer Robson
Australian Prescriber (2023) Vol. 46, Iss. 1, pp. 13-17
Open Access | Times Cited: 5
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys
Craig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 524-537
Open Access | Times Cited: 5
Alteration of prostaglandin production and agonist responsiveness by n-6 polyunsaturated fatty acids in endometrial cells from late-gestation ewes
Zhangrui Cheng, Matthew J. Elmes, S E Kirkup, et al.
Journal of Endocrinology (2004) Vol. 182, Iss. 2, pp. 249-256
Open Access | Times Cited: 32
Prospective clinical performance of CoVarScan in identifying SARS-CoV-2 Omicron subvariants
Kenneth Zhu, Manoj Kumar Sah, Lenin Mahimainathan, et al.
Microbiology Spectrum (2024)
Open Access | Times Cited: 1
Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory Activity
Max J. Bedding, Charlotte Franck, Jason Johansen‐Leete, et al.
ACS Chemical Biology (2023) Vol. 19, Iss. 1, pp. 141-152
Closed Access | Times Cited: 4
IS IT TIME TO REFLECT, NOT ON THE “WHAT” BUT THE “WHY” IN EMERGING WILDLIFE DISEASE RESEARCH?
Richard Kock
Journal of Wildlife Diseases (2018) Vol. 55, Iss. 1, pp. 1-1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top